
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.07 | 2.07 | 0.00 |
Shares | 94.84 | 94.84 | 0.00 |
Other | 3.09 | 3.09 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 39.02 | 22.40 |
Price to Book | 4.81 | 3.19 |
Price to Sales | 3.89 | 2.19 |
Price to Cash Flow | 30.33 | 12.53 |
Dividend Yield | 0.12 | 0.64 |
5 Years Earnings Growth | 10.60 | 14.33 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 34.52 | 20.28 |
Technology | 26.36 | 24.05 |
Industrials | 23.96 | 20.23 |
Consumer Cyclical | 7.08 | 11.33 |
Financial Services | 6.55 | 9.88 |
Utilities | 1.53 | 1.39 |
Number of long holdings: 51
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
RBC Bearings | US75524B1044 | 4.64 | 349.19 | +2.04% | |
Natera Inc | US6323071042 | 4.51 | 162.86 | +1.72% | |
Clearwater Analytics Holdings Inc Class A | - | 3.73 | - | - | |
Q2 Holdings | US74736L1098 | 3.60 | 90.79 | +13.05% | |
BioLife Solutions | US09062W2044 | 3.18 | 22.35 | +4.73% | |
Vertex | US92538J1060 | 3.17 | 37.52 | +0.21% | |
Impulse Dynamics Ireland Series F-1 | - | 3.09 | - | - | |
Guidewire | US40171V1008 | 3.05 | 213.42 | +0.13% | |
Glaukos Corp | US3773221029 | 3.03 | 90.52 | +2.58% | |
Repligen | US7599161095 | 2.89 | 127.85 | +0.76% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Alger Spectra Z | 1.81B | -12.49 | 9.81 | 12.29 | ||
Alger Capital Appreciation Focus Fz | 1.61B | -11.28 | 12.67 | 15.35 | ||
Alger Spectra A | 1.24B | -12.55 | 9.47 | 11.93 | ||
Alger Capital Appreciation Instl I | 994.56M | -12.08 | 10.74 | 13.26 | ||
Alger Capital Appreciation A | 915.7M | -12.11 | 10.82 | 13.23 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review